← Back to Prospects

ArrePath

HotNo broker found

New CEO + fresh funding, advancing to Phase 1, Forrestal Center = Adam's turf

Company Info

Industry
Biotech / Anti-Infectives (AI-driven)
Location
Princeton, NJ
Employees
15+40.0%

Office Situation

Address
303A College Road East, Princeton, NJ 08540 (Forrestal Center)
Current Space
Small office/lab (<10K SF est.)
Lease Expiry
Not found

Funding

Total Raised
~$15M+ (multiple rounds + $3.7M CARB-X grant)
Last Round
New financing round + CARB-X $3.7M grant
Round Date
Apr 1, 2025

Decision Makers

Kevin KrausePrimary3rd
CEO
San Francisco, CA
Appointed Nov 2024. Company HQ is Princeton despite CEO being SF-based.

Qualification

Princeton University spinout (Prof. Zemer Gitai) advancing AI-driven antibiotic discovery. New CEO Kevin Krause (Nov 2024). CARB-X $3.7M grant (April 2025). Located in Forrestal Center where Adam has done significant deals. Will need more space as they advance to clinical trials.

Broker Intel

No broker found

No broker relationship found. 303A College Road East is in Princeton Forrestal Village / Carnegie Center area.

Warm Intro Paths

  • 📍
    Adam markets Princeton Corporate Center (5 Independence Way) on Route 1, near ArrePath's Forrestal Center locationCBRE listing
  • 🎓
    Princeton University spinout — Prof. Zemer Gitai, Dept of Molecular BiologyArrePath
  • 📅
    BioNJ Manufacturing Summit (Sep 29, 2026) at Catalent, 104 Campus Dr, PrincetonBioNJ
  • 🏢
    Same building as Antigenix (303A College Road E) — door-knock bothPitchBook

Sources

ClaimSource
Located at 303A College Road EastPitchBook
Kevin Krause appointed CEO Nov 2024ArrePath press release
Princeton University spinout (Zemer Gitai)ArrePath team page
CARB-X $3.7M grantPress release

Events & Touchpoints

Draft Outreach Message

Hi Kevin — Congrats on the CARB-X grant and the momentum at ArrePath! As you advance AP-001 toward Phase 1, your space needs will evolve. I work with Adam Englander at CBRE — we know the Forrestal Center / College Road area deeply and have helped several Princeton biotechs plan their growth. Would love to be a resource when the time comes. — Carly